Spagyric remedies

1. Introduction

Version followed: spagyrics as described by its German-speaking producers and practitioner literature (the Zimpel-method essences now sold by Phylak and by HEIDAK; the Alexander von Bernus/Soluna "Solunate" as set out in Casagrande's Spagyrik; PEKANA "spagyric homeopathic" mixtures), placed beside Swiss, German, UK and US regulatory texts. The psychotherapist works alongside this method and does not make, sell, prescribe or recommend spagyric remedies. The guide describes the method so you can talk about it knowledgeably, then gives your own clinical work alongside it.

What it is, as its producers describe it. Spagyrics is a way of making medicines, mainly from plants (some traditions also use minerals or animal material), that traces itself to Paracelsus (1493-1541). The name is explained as joining Greek roots for "to separate" and "to join": the plant is broken down into components, these are purified, and they are recombined into one preparation [source: Casagrande, Spagyrik, publisher's excerpt; Saint Charles blog "Spagyrik"; HEIDAK FAQ]. Producers describe named stages qualitatively: fermentation, distillation to capture volatile parts, calcination (reducing the residue to ash to obtain mineral salts), filtering, cohobation, and reunion [source: Casagrande excerpt; HEIDAK FAQ]. (Production details are deliberately not given here.)

Core idea of how change happens (as the tradition holds it). In the alchemical model, every substance carries three "philosophical principles", Sal (the bodily, material), Sulphur (the soul or individual) and Mercurius (the spiritual, volatile), which are not the chemical substances of those names [source: Saint Charles blog; Casagrande excerpt]. Separating and recombining is said to release a plant's full potential, more than an ordinary tincture does [source: Junius, Spagyrics, publisher description]. Illness is read through body-soul-spirit, the four elements, seven planetary principles linked to metals and organ systems, and rhythm (including moon phases) [source: Casagrande excerpt]. The stated aim is to restore harmony between the three principles [source: Saint Charles blog]. These are the tradition's own concepts, reported here as attributed beliefs, not as established fact.

History in brief. Producers and practitioner literature name Paracelsus, then Johann Rudolf Glauber, Carl Friedrich Zimpel (19th century), Theodor Krauss, Konrad Johann Glückselig, Cesare Mattei, Strathmeyer and Alexander von Bernus, whose Soluna laboratory was at Tapfheim; Rudolf Steiner corresponded with von Bernus [source: Casagrande excerpt; HEIDAK FAQ]. A secondary account reports that in the Nazi period a lay practitioner who was an SS member was permitted to test spagyric remedies on prisoners at Dachau, with an unknown death toll [source: Ernst 2023, blog] [uncertain: secondary, unverified].

What a client experiences [source: Casagrande excerpt; PEKANA leaflet; Swissmedic]. In the practitioner tradition, a client sees a doctor or Heilpraktiker (Germany), a naturopath or specialist complementary therapist (Switzerland) or similar, who takes a detailed history and forms a view of the person's constitution; individual remedies or ready-made mixtures are then combined into a plan (in the von Bernus tradition, plans for building up, elimination and rhythmic alternation), with lifestyle and daily rhythm also addressed. Others buy ready-made products in pharmacies or online. Products are usually liquid essences or drops, many alcohol-based; some are sold as globules or creams. Leaflets for German products mention possible temporary worsening of complaints ("Erstverschlimmerung") and advise stopping and consulting a doctor if it happens [source: PEKANA leaflet].

Who practises it. Prescribing practitioners (Heilpraktiker, physicians with naturopathic training, Swiss complementary therapists and naturopaths), pharmacies that stock or compound the products, and manufacturers (e.g. Phylak Sachsen, PEKANA Naturheilmittel, Soluna, HEIDAK) [source: Apotheken Umschau product entry; PEKANA leaflet; HEIDAK FAQ; Casagrande excerpt]. There is no single certifying body for spagyric practitioners [uncertain: not verified].

Regulation and status (one line each).

Germany: several spagyric manufacturing methods are written into the Homöopathisches Arzneibuch (HAB); many products are "registered homeopathic medicinal products, therefore without a stated therapeutic indication" and pharmacy-only [source: Casagrande excerpt; PEKANA leaflet; Apotheken Umschau entry].
Switzerland: Swissmedic lets complementary medicines used in "spagyric treatments" be authorised by notification without indication or dosage, with no patient information, for use only in individual treatment or dispensing by trained specialists [source: Swissmedic, notification procedure].
United Kingdom: homeopathic products may carry a Simplified Homeopathic Registration (HR) or National Rules (NR) number; MHRA asks professionals to ask about use and report suspected reactions via Yellow Card [source: MHRA Drug Safety Update 2021]. Whether specific spagyric products hold UK registrations [uncertain: not verified].
United States: products sold as homeopathic are not FDA-approved; FDA's December 2022 guidance sets risk-based enforcement priorities, including products for serious diseases and vulnerable groups [source: FDA guidance 2022].
Evidence status: no controlled clinical trial of spagyric remedies was identified by a critical reviewer in 2023 [source: Ernst 2023] [uncertain: secondary]; no spagyric remedy is an established treatment for any disease.

2. Framework

Spagyrics is a remedy system, not a psychotherapy, so it has no psychotherapeutic phases. The framework below is the psychotherapist's own work alongside a client who uses or is considering spagyric remedies [synthesis, built on MHRA's advice to ask routinely and report, and on the APA Ethics Code standards on competence, cooperation and informed consent].

Phase	Goal	Format	Move on when
A. Notice and ask	Learn about any complementary use without judgement; record it	Part of intake and periodic review; a few minutes	Use (or none) is recorded with product names as the client gives them
B. Understand	Explore meaning, hopes, expectations, explanatory model	Within ordinary sessions, 1-2 sessions' worth of focus if relevant	You can state in the client's words what they hope for and why
C. Safety and coordination	Screen for risk; with consent, inform doctor or pharmacist	As needed; immediately if risk is present	Risks are addressed or a plan exists; prescriber is aware if the client agrees
D. Decide and integrate	Support informed, values-based choices; return to the therapy's own goals	Ongoing, revisited when circumstances change	The client's decision is their own and medical care is not displaced
E. Report and safeguard	Act on adverse effects, harmful advertising, exploitation, child-protection concerns	When triggered	Report made or decision not to report documented

There is no fixed session count. Most clients need only Phase A and a brief Phase B; Phases C and E are triggered by risk [synthesis].

3. Guiding principles

Curiosity without judgement [synthesis]: ask about remedies as you would ask about sleep or alcohol, so clients disclose them.
Stay in your lane [source: APA Ethics Code 2.01]: you do not assess whether a remedy works or advise on taking it; route medical and pharmaceutical questions to the prescriber or pharmacist.
Never perform, sell, prescribe or recommend [source: APA Ethics Code 3.06, 3.08]: no products, referrals for commission or courses; declare and avoid conflicts of interest.
Respect self-determination [source: APA Ethics Code Principle E]: the client decides; your job is to make the decision informed and free, not to win it.
Cooperate with other professionals [source: APA Ethics Code 3.09]: with consent, share relevant information with the GP, physician or pharmacist.
Consent and confidentiality govern sharing [source: APA Ethics Code 3.10, 4.05]: obtain consent to contact others; disclose without it only where law permits or requires.
Attribute, do not adjudicate, beliefs [synthesis]: describe Sal-Sulphur-Mercurius, energies or principles as the client's or the tradition's view, neither endorsing nor mocking them.
Medical care is not displaced [source: FDA guidance 2022 on serious diseases and delayed treatment; PEKANA leaflet advice to seek medical advice if symptoms persist]: watch for delay or abandonment of effective care.
Products are medicines in law in several countries [source: PEKANA leaflet; Swissmedic; MHRA]: adverse reactions are reportable like any medicine's.
Extra care with vulnerable groups [source: FDA guidance 2022; PEKANA leaflet]: children, pregnancy, breastfeeding, older and immunocompromised people.
Psychological meaning matters [synthesis]: the choice often expresses hope, control, identity or distrust, which belong in therapy.

4. Intervention inventory

All interventions below are the psychotherapist's own work. None involves choosing, supplying, dosing or judging a spagyric product. Where a step rests on a regulator's advice it is cited; the rest is [synthesis] from general psychotherapeutic practice.

4.1 Routine, non-judgemental inquiry and recording

Purpose / when: at intake and at periodic reviews, and whenever a client mentions drops, essences, a Heilpraktiker or naturopath, or a new physical complaint. MHRA asks health professionals to ask about herbal and homeopathic products during routine reviews [source: MHRA Drug Safety Update 2021]; the same habit fits therapy [synthesis].
Steps: (1) Normalise: say many people use complementary products. (2) Ask open questions: what they take or use, from whom, for what hope, since when. (3) Record the product names, manufacturer and any registration number exactly as the client gives them or as on the label (MHRA lists these as the details a report needs). (4) Ask who else knows (GP, psychiatrist, pharmacist). (5) Note it in the record without evaluative comment.
Example language (illustrative): "Lots of people I see use natural or complementary remedies alongside other care. Is there anything like that you're using at the moment, drops, essences, anything from a naturopath?" / "Would you be willing to bring the bottle or a photo of the label next time, so I've got the name right in my notes?"
Watch for: hesitation or shame (a sign the client expects disapproval); vague answers about who prescribed it; products bought online without a label in the client's language. It is working when the client volunteers changes later without prompting.

4.2 Exploring meaning, hopes, expectations and explanatory model

Purpose / when: once use is known and seems meaningful to the client, or when it links to therapy themes (control, health worry, identity, trust in doctors) [synthesis].
Steps: (1) Ask what drew them to spagyrics specifically (the alchemical tradition, a practitioner, a recommendation, a family custom). (2) Ask what they understand the remedy does, in their words; if they use the tradition's language of body, soul and spirit or Sal, Sulphur and Mercurius, reflect it as their view. (3) Explore hopes and the outcome they would count as success. (4) Explore what the consultations give them besides the remedy: time, being listened to, a sense of being seen as a whole person. (5) Explore relationship to conventional medicine: trust, past experiences, fears. (6) Link, if useful, to therapy goals.
Example language (illustrative): "What made this approach feel right for you?" / "When you talk about bringing body and soul back into balance, what would that look like on an ordinary day?" / "What does your practitioner offer that you haven't found elsewhere?"
Watch for: hope that has become the only plan; distrust of medicine rooted in a past injury or dismissal (material for therapy); identity strongly tied to "natural" living; magical or catastrophic thinking about health. It is working when the client can describe their own reasons and doubts, and the conversation feels collaborative rather than defensive.

4.3 Responding when the client asks for your opinion or a recommendation

Purpose / when: the client asks "Do you think it works?" or "Which one should I take?" [synthesis, grounded in APA Ethics Code 2.01 and 3.06].
Steps: (1) Thank them for asking. (2) State your role: you do not recommend, prescribe or advise on remedies or medicines. (3) Give neutral, sourced facts only if asked: in Germany many products are registered without a stated indication; in the US none sold as homeopathic is FDA-approved; good trials are lacking. (4) Hand back to the client's values and to the right expert (doctor, pharmacist). (5) Never share personal product preferences, discount codes or practitioner referrals.
Example language (illustrative): "It's outside what I can advise on: I don't recommend or advise on remedies. What I can do is help you think through what matters to you and who could answer the medical side, like your GP or pharmacist."
Watch for: the client experiencing this as rejection (repair: affirm interest in their experience); pressure to endorse in order to keep the alliance. Working when the client accepts the boundary and still talks openly.

4.4 Supporting informed, values-based decisions without coercion

Purpose / when: the client is deciding whether to start, continue, add or rely on spagyric remedies, especially in place of medical care [synthesis; APA Ethics Code Principle E].
Steps: (1) Clarify the decision in one sentence. (2) Elicit options, including combinations with medical care. (3) Elicit what the client values most (safety, naturalness, control, cost, relationships). (4) Ask what information they have and from whom; help them list questions for their doctor or pharmacist. (5) Name the regulatory facts neutrally if relevant (registered without indication; not FDA-approved). (6) Summarise without steering, and check the decision is theirs and not driven by fear, shame or group pressure. (7) Revisit when circumstances change. No specific decision aid for spagyrics is known [uncertain: not verified].
Example language (illustrative): "Let's put the options side by side, including keeping your current treatment as well. What matters most to you here?" / "Whatever you choose, I'd like you to choose it with full information and not because anyone is pressuring you, me included."
Watch for: the therapist's own urge to persuade (a rupture risk); all-or-nothing thinking; a practitioner telling the client to stop prescribed treatment (see 4.6). Working when the client can state reasons, risks they accept and how they will review the decision.

4.5 Coordinating with the doctor or pharmacist (with consent)

Purpose / when: the client takes prescribed medicines, has a medical condition, is pregnant, or reports new symptoms; MHRA asks professionals to remind patients to involve health professionals and to list all products when reactions occur [source: MHRA Drug Safety Update 2021; APA Ethics Code 3.09, 3.10, 4.05].
Steps: (1) Explain why coordination helps (interactions, symptoms, full picture). (2) Get specific consent: who, what, how. (3) Prefer the client informing the prescriber themselves; offer a short letter or a joint call. (4) Share only what is relevant: product names as labelled, start date, the reason you are writing. (5) Document consent and contact. (6) Do not interpret the medical reply for the client beyond what the doctor states.
Example language (illustrative): "Would it be all right if you told Dr [name] about the drops, or if I mentioned them in my letter? Doctors and pharmacists like to know everything someone takes."
Watch for: fear that the doctor will scold them (role-play the conversation); refusal (respect it unless risk overrides confidentiality under law). Working when the prescriber knows and the client feels supported rather than reported.

4.6 Recognising and responding to risk: delay or abandonment of medical care

Purpose / when: any sign that a remedy is replacing diagnosis, effective treatment or monitoring; FDA prioritises enforcement against homeopathic products for serious diseases because users may delay effective treatment, and leaflets advise medical advice if symptoms persist [source: FDA guidance 2022; PEKANA leaflet].
Steps: (1) Ask directly about current medical care and any changes. (2) If prescribed medicines (including psychiatric medicines) were stopped or reduced, do not advise either way; urge prompt contact with the prescriber and support the client to make it. (3) If symptoms are severe, new or worsening, encourage urgent medical review; follow your emergency procedures if needed. (4) Explore the reasons (fear of side effects, distrust, practitioner advice) without arguing. (5) Document the conversation and your advice to seek medical care. (6) If a practitioner told the client to stop treatment or made disease-cure claims, consider reporting routes (4.11).
Example language (illustrative): "I'm not able to advise on medicines, but I'm concerned about stopping something your doctor prescribed without talking to them. Could we work out together how you'll contact them this week?"
Watch for: serious illness (including cancer) being treated only with remedies; worsening mental state after stopping psychiatric medicines; secrecy. No spagyric remedy is a treatment for cancer or other physical disease [source: Ernst 2023 on absence of controlled trials] [uncertain: secondary].

4.7 Alcohol content and clients in recovery

Purpose / when: many spagyric essences are alcohol-based liquids and leaflets state their alcohol content [source: PEKANA leaflet]. Relevant for clients with alcohol use disorder, in recovery, on medicines that interact with alcohol, or with religious abstinence [synthesis].
Steps: (1) Ask whether the product is a liquid and whether the client knows it contains alcohol. (2) Invite them to read the label or ask the pharmacist. (3) For clients in recovery, explore what this means for their recovery plan, and link with their addiction team or prescriber with consent. Do not advise on taking or stopping it.
Example language (illustrative): "Some of these drops are made with alcohol. Is that something you'd want to check, given how important your recovery is to you?"
Watch for: craving, relapse or use of remedies as a socially acceptable route to alcohol. Working when the client makes the check and talks about it openly.

4.8 Children, pregnancy and breastfeeding

Purpose / when: a parent gives remedies to a child, or a client is pregnant or breastfeeding. FDA names infants, children and pregnant women among vulnerable populations for enforcement priority; one PEKANA leaflet advises use in pregnancy and breastfeeding only after consulting a doctor and not in younger children because experience is insufficient [source: FDA guidance 2022; PEKANA leaflet].
Steps: (1) Ask about the child's or pregnancy care: is a doctor, midwife or paediatrician involved and informed? (2) Encourage the parent or client to tell that professional; offer to coordinate with consent. (3) Involve the child in age-appropriate terms (assent) where the work is with the family [synthesis]. (4) If a child is being deprived of necessary medical care, or a serious illness is being treated only with remedies, follow your safeguarding procedures and consult your safeguarding lead [synthesis; local safeguarding law applies].
Example language (illustrative): "Does your midwife know about the drops? It's one of those things they always like to hear about." / "I can hear how much you want to protect her. Has her doctor seen her since the fever started?"
Watch for: missed medical appointments, untreated serious symptoms, a parent under the influence of a practitioner or group. Working when the child's or pregnancy care team is informed and involved.

4.9 Financial exploitation, commerce and group pressure

Purpose / when: heavy spending on remedies or consultations, debt, pressure to buy more, a practitioner who also sells products, or a community where questioning the method is discouraged [synthesis; APA Ethics Code 3.06, 3.08 on the therapist's own conflicts].
Steps: (1) Ask neutrally about cost and how it feels to the client. (2) Explore who benefits financially from the advice they receive. (3) Explore social pressure: what happens if they voice doubts? (4) Support the client to set their own limits. (5) Model clean boundaries: you sell nothing, take no referral fees and recommend no practitioners.
Example language (illustrative): "How do the costs sit with you at the moment?" / "If you said to the group that you weren't sure, how would that go?"
Watch for: secrecy from family about spending; fear of leaving a group; testimonials or promises of cure being used to sell. Working when the client can talk about cost and doubt freely and makes choices within their means.

4.10 Responding to reported adverse effects or "initial worsening"

Purpose / when: the client reports new or worse symptoms after starting a remedy. German leaflets describe a temporary worsening ("Erstverschlimmerung") and advise stopping and consulting a doctor; MHRA notes harm from manufacturing errors and asks professionals to consider herbal and homeopathic products when reactions occur [source: PEKANA leaflet; MHRA Drug Safety Update 2021].
Steps: (1) Take the report seriously; do not interpret it as healing or as harm. (2) Direct the client to their doctor or pharmacist promptly; urgent care if severe. (3) Encourage the client to keep the product and label. (4) Offer to help with, or make with consent, a Yellow Card or equivalent report (4.11). (5) Document.
Example language (illustrative): "I can't tell whether that's connected, but it's important a doctor or pharmacist looks at it. Can you call today? Keep the bottle in case they want to see it."
Watch for: a practitioner reframing worsening as a sign the remedy is working, which can delay assessment [synthesis]. Working when the symptom is medically assessed.

4.11 Reporting routes

Purpose / when: suspected adverse reactions, products making disease claims, advice to abandon medical care, exploitation, or child-protection concerns.
Steps and routes:
- UK: suspected reactions to licensed or unlicensed herbal or homeopathic products go to MHRA's Yellow Card scheme; useful details include brand, ingredients, manufacturer, registration number, condition treated, other recent medicines and practitioner details; a photo of the label can be sent [source: MHRA Drug Safety Update 2021]. Misleading advertising: the Advertising Standards Authority [uncertain: not verified].
- US: FDA MedWatch for adverse events [source: FDA guidance 2022 refers to MedWatch reports]; deceptive health marketing to the Federal Trade Commission [uncertain: not verified].
- Switzerland: Swissmedic is the authorising authority for these products [source: Swissmedic]; its adverse-reaction reporting channel [uncertain: not verified].
- Germany: BfArM for adverse reactions to medicines [uncertain: not verified]; complaints about Heilpraktiker practice go to the local health office [uncertain: not verified].
- Professional misconduct by a licensed clinician: the relevant licensing board; children: local safeguarding services [synthesis].
Example language (illustrative): "Reports like this help regulators spot problems. Would you like to make one together, or shall I make it with your permission?"
Watch for: confidentiality: report without identifying the client unless consent or law allows [source: APA Ethics Code 4.05]. Working when the report is made and documented.

4.12 Health anxiety and somatic symptom presentations

Purpose / when: remedy use is driven by persistent health worry, checking and reassurance-seeking, or by distressing bodily symptoms with no medical explanation; see Domain II for full protocols (CBT for health anxiety, somatic symptom approaches) [synthesis; cross-reference Domain II].
Steps: (1) Map the cycle: trigger, worry, checking or remedy-seeking, short-term relief, return of doubt. (2) Ask whether seeking new remedies or consultations works as reassurance. (3) Agree a shared formulation without disputing the remedy. (4) Use the established Domain II interventions (psychoeducation, attention training, reducing checking and reassurance, behavioural experiments) as you would for any reassurance behaviour. (5) Keep medical review in place for new or changing symptoms.
Example language (illustrative): "When the worry comes, what do you find yourself doing? ... And how long does the relief last?"
Watch for: remedy-switching as a form of reassurance-seeking; avoidance of medical tests out of fear. Working when worry and checking decrease and the client relies less on any one source of reassurance.

4.13 Documentation and boundaries

Purpose / when: throughout [source: APA Ethics Code 3.10, 4.05; synthesis].
Steps: record what the client uses (as named), conversations about risk, consent to coordinate, advice to seek medical care, reports made, and that you did not recommend or supply any product. Include in informed consent to therapy that you do not advise on remedies or medicines [source: APA Ethics Code 10.01, adapted].
Example language (illustrative): "I'll make a note that you're using these drops and that we talked about telling your GP."
Watch for: notes that read as endorsement or ridicule. Working when the record is factual and neutral.

5. Handling problems

The sources on spagyrics do not address psychotherapy, so all guidance in this section is [synthesis] unless a source is named.

Client will not disclose or minimises use. Return to the normalising frame (4.1); explain why you ask (whole picture, safety), not to judge. Ask about "anything from a pharmacy or naturopath" rather than "alternative medicine". Accept partial disclosure and revisit.
Client becomes defensive when medical care is mentioned. Separate the two questions: respect for their remedy, and keeping a doctor informed. Reflect the hurt or distrust behind it (past dismissal, side effects). Use motivational interviewing style: elicit their own reasons to keep medical contact.
Client asks you to agree that the remedy works, or to say it doesn't. Hold the boundary (4.3). Name that your opinion is not what matters for their decision; offer the factual regulatory status if asked, without editorial.
Stuck: the remedy has become the client's whole plan for a serious condition. Name concern directly and once, with warmth; explore what would need to happen for them to see a doctor; involve family or other supports with consent; document. If risk is to a child or the client lacks capacity, follow safeguarding and capacity procedures. Respect a capable adult's informed refusal of medical treatment while keeping the door open.
Rupture: the client feels judged. Acknowledge it, take responsibility for your part, re-state your stance (curious, not deciding for them), and ask what would help. Check whether the rupture repeats earlier experiences with doctors.
Rupture: the therapist's own scepticism or enthusiasm leaks. Use supervision. Neither ridicule nor share personal enthusiasm; disclosing your own use of complementary products risks steering the client [source: APA Ethics Code 3.06 on objectivity, applied].
Overwhelm: health fears flood the session. Ground first; move to the health-anxiety formulation (4.12; Domain II) once settled; keep medical review in place.
Non-adherence to psychiatric medication linked to remedy use. Do not advise on the medicine. Help the client voice concerns to the prescriber; offer a joint conversation with consent (4.5). Monitor mental state closely after any change and follow risk procedures.
Reported worsening framed as healing ("initial worsening"). Leaflets themselves advise stopping and seeing a doctor if it occurs [source: PEKANA leaflet]; use that as common ground and encourage medical assessment (4.10).
Spending and pressure from a practitioner or community. Explore autonomy and cost (4.9). If the client describes coercive, isolating or exploitative dynamics, treat this as a high-control relationship issue and support safety planning.
Alcohol-based products in recovery. Explore openly and connect with the recovery plan and team (4.7).
Family conflict over remedy use (e.g. partners or parents disagreeing). Offer a joint session focused on shared values (the person's health and autonomy), not on whether the remedy works; keep child safeguarding in view (4.8).
The client wants you to collaborate with their spagyric practitioner. With consent, limited information-sharing about wellbeing and risk may help coordination; do not co-plan remedy use or accept referral arrangements [source: APA Ethics Code 3.06, 3.09, applied].
Historical distress. Some clients may be troubled to learn of reported Nazi-era misuse of spagyric remedies in experiments on prisoners [source: Ernst 2023] [uncertain: secondary, unverified]; respond to the distress without using it to argue against their choice.

Sources

Web sources:

Books cited:

Casagrande, C. (4th ed., preface 2019). Spagyrik (nach Alexander von Bernus). Stuttgart: Thieme. (Excerpt only.)
Junius, M. M. (2007). Spagyrics: The Alchemical Preparation of Medicinal Essences, Tinctures, and Elixirs. Healing Arts Press. (Publisher description only.)

← Previous · XII-069Gem elixirs Next · XII-071 →Gemmotherapy